Our results provide evidence that MTA1 promotes hepatocellular carcinoma progression by proteasomal-mediated degradation of DNA-PK, resulting in inhibition of H1.2 phosphorylation. This evidence concerns the gene PRKDC and hepatocellular carcinoma.